CANCER BIOLOGY: Renal Cell Carcinoma

This book provides a comprehensive examination of RCC from its epidemiological landscape to the molecular biology driving its progression, with a particular focus on the promising role of miRNAs as both biomarkers and therapeutic targets. By delving into miRNA profiling, their dysregulation in RCC, and their potential in personalized medicine, we aim to provide a holistic perspective on how miRNAs could revolutionize the management of RCC. We also explore the challenges in integrating miRNA-based diagnostics and therapeutics into clinical practice, considering the clinical and regulatory hurdles that lie ahead. Through this exploration, we aim to inspire future innovations and collaborations in the field of RCC research, ultimately contributing to improved patient outcomes and the development of novel, targeted therapies. Read more